Latest / The Fiscal Policy Podcast with Fexingo: Government Budgets, Stimulus, and Public Spending
Why Government Health Programs Overpay for Drugs by 50 Percent
In this episode of The Fiscal Policy Podcast, Lucas and Luna explore how the US government's drug-pricing system for Medicare and Medicaid results in overpayments of over 50 percent compared to other countries. They focus on a specific case: the drug insulin, which costs US taxpayers $6,000 per patient per year versus $1,200 in Canada. The hosts discuss the role of pharmacy benefit managers (PBMs), the lack of direct negotiation, and recent policy proposals like the Inflation Reduction Act's Medicare negotiation provision. Lucas breaks down the mechanics of 'list price vs. net…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.